Labshake search
Citations for R&D Systems :
801 - 850 of 3472 citations for 1 tert Butoxy 4 methyl 2 nitrobenzene since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Pathology 2023Quote: ... Tissue sections were labeled overnight at 4°C in a humid chamber with goat anti-mouse CLEC4F (AF2784, R&D systems) and rat anti-mouse/human CD324 (DECMA-1 ...
-
bioRxiv - Immunology 2023Quote: ... Cells were cultured for 4 days in the presence of 20ng/ml murine recombinant IL-12 (R&D systems; 419-ML). The proportion of IFNγ-secreting CD4+ T-cells (Th1 cells ...
-
bioRxiv - Immunology 2024Quote: ... U-bottom 96 well plates in Essential 8 medium supplemented with 50 ng/mL BMP-4 (R&D Systems, 314-BP010) and 10 μM Rock inhibitor ...
-
bioRxiv - Cell Biology 2024Quote: ... medium was changed to experimental medium (Ham’s F-12 supplemented with 4% HS and 1X penicillin/streptomycin [R&D Systems; B21210]) for 24 hours ...
-
bioRxiv - Microbiology 2024Quote: ... antibody, anti-Beclin 1 rabbit (Cell Signaling Technology, 3495; 1:500 or sheep (R&D Systems, AF5295; 1:250) antibody ...
-
bioRxiv - Genomics 2023Quote: ... Primary antibodies (FUS 1:100 Santa Cruz Biotech sc-47711; ISL1 1:500 Abcam ab109517; OLIG2 1:100 R&D Systems AF2418; NFM 1:1000 Merck MAB1621) were added in 1% BSA and incubated at 4degC overnight ...
-
bioRxiv - Developmental Biology 2020Quote: ... or Tgfb1/2/3 ligands (10ng/ml, each) (R&D systems, 240-B/302-B2/243-B3) was placed in the upper and lower chambers ...
-
bioRxiv - Immunology 2022Quote: ... CFSE-labelled cells were then resuspended in R10 media supplemented with recombinant IL-2 (R&D system) and 2-mercaptoethanol (Themo Fisher Scientific ...
-
bioRxiv - Immunology 2021Quote: ... and 2.5 ng/ml recombinant mouse IL-15 and 100 units of IL-2 (R&D Systems).
-
bioRxiv - Bioengineering 2021Quote: ... ELISA kits for FGF-2 and TGF-β1 were purchased from R&D Systems (Minneapolis, MN, USA) while the ELISA kit for Nodal was obtained from Abcam (Cambridge ...
-
bioRxiv - Cell Biology 2020Quote: Supernatant levels of BMP2 were quantified using a BMP-2 Quantikine ELISA kit (R&D Systems #DBP200), without significant deviations from manufacturer’s instructions.
-
bioRxiv - Physiology 2020Quote: ... Each treatment infusion was 2 μL of PBS or leptin (10μg/2μL, R&D Systems, Minneapolis, MN). Data collected 30 minutes prior and 30 minutes after the ICV injections were excluded from the analysis ...
-
bioRxiv - Microbiology 2020Quote: ... The transduced cells were stained with anti-human ACE-2 polyclonal goat IgG (AF933, R&D Systems) primary antibody at 1 ug/mL and donkey anti-goat IgG conjugated to Alexa Fluor 488 (ab150129 ...
-
bioRxiv - Immunology 2022Quote: ... The binding kinetics for the interaction between hmAbs and SARS-CoV-2 Spike protein (R&D Systems) was determined by injecting four concentrations of SARS-CoV-2 Spike (25 nM highest concentration ...
-
bioRxiv - Cell Biology 2022Quote: ... mice were given intra-articular injections of recombinant mouse R-spondin 2 (500 ng, R&D Systems) or vehicle (phosphate-buffered saline ...
-
bioRxiv - Cancer Biology 2021Quote: ... a standard direct ELISA was performed with DuoSet Ancillary Reagent Kit 2 (R&D systems, Minneapolis, MN). After coating wells with recombinant human EGFR (1μg/mL) ...
-
bioRxiv - Developmental Biology 2021Quote: ... Media was changed every 2 days using differentiation media supplemented with 100ng/ml VEGF (R&D Systems) and 50ng/ml bFGF (R&D Systems) ...
-
bioRxiv - Immunology 2020Quote: ... Collected ILCs were rested in 10ng/mL IL-2 and IL-7 (R&D Systems, Minneapolis, MN) in T-cell media (TCM ...
-
bioRxiv - Genetics 2023Quote: ... and receptor activator of nuclear factor kappa-B ligand (RANKL) (2 ng/mL; R&D systems; USA) to induce osteoclastogenesis ...
-
bioRxiv - Immunology 2023Quote: ... LCN2 in the clear supernatants was quantified using Mouse Lipocalin-2/NGAL DuoSet ELISA (R&D systems) according to the manufacturer’s instructions.
-
bioRxiv - Immunology 2023Quote: ELISA plates were coated with 2 µg/ml mouse anti-His tag antibody (R&D Systems, MAB050) and blocked as described above ...
-
bioRxiv - Biochemistry 2023Quote: The human ADGF (Recombinant Human Adenosine deaminase 2/CECR1) #7518-AD-010 was from R&D Systems, Minneapolis ...
-
bioRxiv - Cell Biology 2020Quote: ... anti-decorin (1:500, 1% casein, AF1060, R&D Systems, MN, USA), anti-biglycan (1:500 ...
-
bioRxiv - Developmental Biology 2020Quote: ... or 1 ng/mL PTH aa1-34 (R&D systems 3011/1) to αMEM media induced osteogenesis ...
-
bioRxiv - Microbiology 2021Quote: ... or anti-hNP-1 (2.5 – 20 μg ml−1; R&D Systems) antibodies before serum-adaptation was carried out.
-
bioRxiv - Developmental Biology 2022Quote: ... Prox1 (11-002, AngioBio, 1:200; AF2727, R&D Systems, 1:200), LYVE1 (AF2125 ...
-
bioRxiv - Neuroscience 2020Quote: ... goat anti IGFBPL-1 (R&D Systems, product no: AF4130, (1:50)) ...
-
bioRxiv - Neuroscience 2022Quote: ... anti-PAX6 (BioLegend, 901301, 1:300; R&D Systems, AF8150, 1:500), anti-PCNA (Santa Cruz Biotechnology ...
-
bioRxiv - Bioengineering 2024Quote: ... goat anti-jagged 1 (1:150, AF599, R&D Systems, RRID: AB_2128257), rabbit anti-RET (1:200 ...
-
bioRxiv - Cancer Biology 2024Quote: ... mouse VEGFR1/Flt-1 antibody (1 μg/mL, R&D Systems, #AF471), or a combination of anti-VEGFR1 and VEGF-B for 30 hrs ...
-
bioRxiv - Bioengineering 2023Quote: ... goat anti-jagged 1 (1:150, AF599, R&D Systems, RRID: AB_2128257), rabbit anti-RET (1:200 ...
-
bioRxiv - Immunology 2023Quote: ... and IL-1 beta/IL-1 F2 DuoSet ELISA (R&D systems) according to the manufacturer’s instructions.
-
bioRxiv - Cancer Biology 2021Quote: ... MO) or using 50 μg/ml of LPS plus 50 ng/ml of mouse IL-4 from R&D Systems (Minneapolis, MN). After 4 days in complete RPMI media at 37°C ...
-
bioRxiv - Cell Biology 2020Quote: ... sections were incubated overnight at +4°C with primary antibody monoclonal mouse anti-Human ACE2 (cat.MAB933, R&D System, Minneapolis, MN, USA) diluted 1:33 (15 μg/ml ...
-
bioRxiv - Developmental Biology 2021Quote: ... and genomic DNA regions of interest were isolated using 4 μg of antibody against Brachyury (R&D Systems, cat# AF2085, lot# KQP0719121). Complexes were washed ...
-
bioRxiv - Bioengineering 2021Quote: ... primary antibodies (E-cadherin, AF748, R&D Systems, 4 μg/mL; vimentin, ab92547, Abcam, 0.5 μg/mL; CD31, AF3628, R&D Systems, 10 μg/mL ...
-
bioRxiv - Cell Biology 2021Quote: ... The membrane was blocked with blocking buffer for 30 min at room temperature and followed by incubation with primary antibody overnight at 4°C (all primary antibodies used for dot blot were purchased form, R&D systems; anti-Cathepsin A ...
-
bioRxiv - Microbiology 2021Quote: ... gradient and treated with macrophage colony stimulator (M-CSF) or granulocyte-macrophage-stimulating factor (GM-CSF) and IL-4 (R&D system) respectively for 7 days ...
-
bioRxiv - Immunology 2022Quote: The supernatants collected from LPS-stimulated moDCs with or without fhFABP1 (25 μg/ml) were pooled from 4 donors in equal volume and subjected to the Proteome Profiler Human XL Cytokine Kit (R&D Systems) according to the manufacturer’s instructions ...
-
bioRxiv - Immunology 2022Quote: ... supplemented with recombinant human IL-4 (50 ng/mL) and recombinant human GM-CSF (100 ng/mL) (R&D Systems, Minneapolis, MN) with one additional supplement of fresh media and cytokines at day 3 of culture as previously described 12 ...
-
bioRxiv - Immunology 2022Quote: ... at a final concentration of 60 pmol/peptide/mL in CTLm supplemented with 400 U/mL IL-4 and 10 ng/mL IL-7 (R&D Systems) for three days ...
-
bioRxiv - Immunology 2020Quote: ... were generated by incubation of bone marrow cells for 5 days in the presence of 10 ng/ml of recombinant murine GM-CSF and IL-4 (R&D Systems), as described previously [40] ...
-
bioRxiv - Immunology 2020Quote: ... in serum-free medium (5 x 106/4 ml of AIM-V) supplemented with M-CSF (50 ng/ml; R&D Systems) over 7 days followed by 18 h treatment with IFN-γ (20 ng/ml ...
-
bioRxiv - Developmental Biology 2021Quote: ... and then further differentiated on days 4–6 with CDM3 base media supplemented with Activin A (10 ng/mL; R&D Systems), BMP4 (30 ng/mL ...
-
bioRxiv - Microbiology 2020Quote: Secretory leukocyte peptidase inhibitor (SLPI) and Boc-Gln-Ala-Arg-7-Amino-4-methylcoumarin (BOC-QAR-AMC) were obtained from R&D systems. Camostat mesylate was obtained from Sigma Aldrich ...
-
bioRxiv - Immunology 2021Quote: ... Membranes were blocked in 5% nonfat dry milk in TBST and probed overnight at 4°C with antibodies recognizing ERAP1 (AF2334, R&D Systems), ERAP2 (AF3830 ...
-
bioRxiv - Microbiology 2021Quote: ... and then treated with macrophage colony stimulator (M-CSF) or granulocyte-macrophage-stimulating factor (GM-CSF) and IL-4 (R&D system) for 7 days.
-
bioRxiv - Immunology 2020Quote: ... non-tissue culture plates were coated overnight at 4゜C with recombinant human B7-H3 protein (R&D Systems, Minneapolis, MN) at 10 μg/well in 500 μL of PBS ...
-
bioRxiv - Cell Biology 2023Quote: ... 1 x 106 BM cells were incubated at 37°C or 4°C for 45 min with or without Cxcl12 (10 nM, R&D Systems). The reaction was stopped by adding ice-cold RPMI and brief centrifugation at 4°C ...
-
bioRxiv - Bioengineering 2024Quote: ... Hydrogels (n=3) were incubated for 4 hours in a solution of FBS-free DMEM supplemented with 10% Resazurin dye (AR002, R&D Systems) at 37°C ...